Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_assertion type Assertion NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_head.
- NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_assertion description "[These data indicate that in addition to its effects on growth, survival, and motility, ERK activation in MM attenuates a host antitumor immune response, implicating CD200 and its interaction with the CD200 receptor as a potential therapeutic target for MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_provenance.
- NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_assertion evidence source_evidence_literature NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_provenance.
- NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_assertion SIO_000772 18008004 NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_provenance.
- NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_assertion wasDerivedFrom befree-20150227 NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_provenance.
- NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_assertion wasGeneratedBy ECO_0000203 NP644412.RACuWTygnO0VaMHPwtK79S-w5bAaUGDUD_eynCL-uh-9E130_provenance.